Business Daily Media


Business News

Catalent Pharma Solutions appoints Stephen Vanni as General Manager

  • Written by Ed Dutton



Somerset, N.J. – July 5, 2016
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Stephen Vanni as General Manager of the company’s Braeside facility in Melbourne, Australia.

Catalent’s 331,055 sq. ft. Braeside facility is one of the company’s key strategic hubs within the Asia Pacific region, and has both softgel and solid dose manufacturing operations.

Mr. Vanni joins Catalent from Aspen Pharma, where he was Southern Region Plant Manager, based at the company’s Dandenong facility, and had full responsibility over the plant’s safety, quality and regulatory compliance, as well financial oversight on investment and revenue.

Stephen will play a central role in the strategic growth of Catalent’s business within Australia and the greater Asia-Pacific region,” commented Mark Bisset, President of Catalent Asia Pacific. “His insight and experience will be invaluable to our growing Executive Leadership team as we look to continue to expand our reach within the consumer health and over the counter formulations space in this marketplace.”

Mr. Vanni has over 20 years’ experience within the chemical and food production industries, and has previously worked for ICI Australia, and Bristol-Myers Squibb. He holds a MSc. in Chemistry from Monash University, Melbourne.

In 2015, Catalent announced the acquisition of a facility in Cromer, New South Wales, from PharmaPak, to offer primary and secondary packaging of oral pharmaceutical dose forms. This facility, alongside Braeside, supports Catalent’s integrated supply to customers across Australia, New Zealand and the Asia Pacific region.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com

 

More products. Better treatments. Reliably supplied.™

Business Daily Media Business Development

How to Write a Startup Pitch to Attract Investors

The number of startups is growing worldwide year by year. And it’s getting more challenging for innovative entrepreneursto grab the investors’ attention. If you want to get your s...

Daniela McVicker - avatar Daniela McVicker

SMEs urged not to overlook domain names

More shoppers are seeking out Aussie businesses online. A com.au domain name says your business is local.   *  70% of respondents to a survey from auDA said supporting Australia...

auDA - avatar auDA

The 5 Tell-Tale Signs Of a Toxic Workplace

Wearing a mask wears you out. Faking it is fatiguing. The most exhausting activity is pretending to be what you know you aren’t. – Rick Warren Congratulations are in order. ...

Mark LeBusque - author and Founder & Director of The Human Manager - avatar Mark LeBusque - author and Founder & Director of The Human Manager

Australia's first 1 Hotel and Homes continues to sail ahead

Riverlee’s $500 million Seafarers project continues to sail ahead  Riverlee’s $500 million mixed-use Seafarers project continues to sail ahead following the State Government’s ...

Green Point Media - avatar Green Point Media

Writers Wanted



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion